Decibel Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch DBTX and buy or sell other stocks, ETFs, and their options commission-free!

About DBTX

Decibel Therapeutics is a developer of hearing disorder therapeutics intended to protect, repair and restore hearing. The company's therapeutics have provided insights into the link between hearing dysfunction and inner ear pathology and it has capabilities to encompass animal models, drug delivery to the inner ear, imaging, inner ear PK/PD modeling and measurement, bioinformatics, genetics and target identification, enabling patients to experience hearing loss therapies with different forms of hearing disorders for their recovery. 

CEO
Laurence E. Reid, PhD
CEOLaurence E. Reid, PhD
Employees
Employees
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2015
Founded2015
Employees
Employees

DBTX Key Statistics

Market cap
123.37M
Market cap123.37M
Price-Earnings ratio
-1.94
Price-Earnings ratio-1.94
Dividend yield
Dividend yield
Average volume
267.14K
Average volume267.14K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$5.40
52 Week high$5.40
52 Week low
$1.61
52 Week low$1.61

People also own

Based on the portfolios of people who own DBTX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.